TITLE

Long-Term Use of Short- and Long-Acting Nitrates in Stable Angina Pectoris

AUTHOR(S)
Kosmicki, Marek Antoni
PUB. DATE
May 2009
SOURCE
Current Clinical Pharmacology;May2009, Vol. 4 Issue 2, p132
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Long-acting nitrates are effective antianginal drugs during initial treatment. However, their therapeutic value is compromised by the rapid development of tolerance during sustained therapy, which means that their clinical efficacy is decreased during long-term use. Sublingual nitroglycerin (NTG), a short-acting nitrate, is suitable for the immediate relief of angina. In patients with stable angina treated with oral long-acting nitrates, NTG maintains its full anti-ischemic effect both after initial oral ingestion and after intermittent long-term oral administration. However, NTG attenuates this effect during continuous treatment, when tolerance to oral nitrates occurs, and this is called cross-tolerance. In stable angina long-acting nitrates are considered third-line therapy because a nitrate-free interval is required to avoid the development of tolerance. Nitrates vary in their potential to induce the development of tolerance. During long-lasting nitrate therapy, except pentaerythritol tetranitrate (PETN), one can observe the development of reactive oxygen species (ROS) inside the muscular cell of a vessel wall, and these bind with nitric oxide (NO). This leads to decreased NO activity, thus, nitrate tolerance. PETN has no tendency to form ROS, and therefore during long-term PETN therapy, there is probably no tolerance or cross-tolerance, as during treatment with other nitrates.
ACCESSION #
60435379

 

Related Articles

  • NITROGLYCERIN OINTMENT: A REVIEW. Francis, Gary S.; Hagan, A. D. // Angiology;Dec1977, Vol. 28 Issue 12, p873 

    Presents a review of the efficacy of nitroglycerin ointment, a drug used in the treatment of angina pectoris and in reducing left ventricular end-diastolic and end-systolic volume. Duration of effect of sublingual nitrates; Degradation of oral nitroglycerin agents by hepatic enzymes which result...

  • Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Li, Hongwei; Gutterman, David D.; Rusch, Nancy J.; Bubolz, Aaron; Liu, Yanping // Diabetes;Sep2004, Vol. 53 Issue 9, p2436 

    Coronary microvessels generate reactive oxygen species in response to high glucose (HG), resulting in vasodilator defects involving an impaired function of vascular K(+) channels. Inhibition of voltage-gated K(+) (K(v)) channels by peroxynitrite (ONOO(-)), formed by the interaction of superoxide...

  • Nitroglycerine: Solving a Century-Old Puzzle.  // Medical Update;Jun2002, Vol. 27 Issue 12, p4 

    Presents the findings of a study conducted by researchers at Duke University Medical Center which identified the enzyme responsible for the negative effects of nitroglycerine to patients with angina.

  • Nebivolol.  // Reactions Weekly;3/9/2013, Issue 1443, p29 

    An abstract of the article "Resolution of nebivolol-induced coronary vasospasm by intracoronary nitroglycerin during a coronary angiogram," by N. I. Akkus and colleagues is presented.

  • Drug treatment of chronic stable angina pectoris.  // British Medical Journal;2/25/1978, Vol. 1 Issue 6111, p462 

    Identifies the importance of beta-adrenoceptor-blocking drugs for the management of patients with chronic stable angina pectoris. Reduction of the frequency and severity of anginal attacks; Reduction of glyceryl trinitrate consumption; Ameleoration of electrocardiographic ST segment depression;...

  • Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries. Ninomiya, Yuichi; Hamasaki, Shuichi; Saihara, Keishi; Ishida, Sanemasa; Kataoka, Tetsuro; Ogawa, Masakazu; Orihara, Koji; Oketani, Naoya; Fukudome, Tsuyoshi; Okui, Hideki; Ichiki, Tomoko; Shinsato, Takuro; Kubozono, Takuro; Mizoguchi, Etsuko; Ichiki, Hitoshi; Tei, Chuwa // Heart & Vessels;Mar2008, Vol. 23 Issue 2, p83 

    The comparative long-term antianginal efficacy of long-acting nitrates versus calcium channel antagonists remains unclear. The goal of the present study was to compare the coronary endothelial cell function and coronary artery vasoconstriction between patients with normal or mildly diseased...

  • The Transdermal Administration of Nitrates: An Overview. Demma, Frank J.; Wilson, Richard R. // Angiology;Jan1983, Vol. 34 Issue 1, p1 

    Nitroglycerin has been the mainstay of the medical management of angina pectoris for over 100 years. The long-held clinical impression of the efficacy of nitroglycerin has now been clearly documented in controlled clinical trials designed to evaluate objective response to antianginal agents.'"'...

  • A Double-Blind, Parallel-Group Study of Amlodipine versus Long-Acting Nitrate in the Management of Elderly Patients with Stable Angina. Hall, Roger; Chong, Camilla // Cardiology;2001, Vol. 96 Issue 2, p72 

    Ninety-seven elderly patients with stable angina were included in a 28-week, randomized, double-blind, parallel-group comparison of amlodipine 5–10 mg and isosorbide mononitrate 25–50 mg once daily. The total exercise time, as limited by angina, was recorded together with the...

  • Use of Ranolazine in Patients with Stable Angina Pectoris. Khera, Sahil; Kolte, Dhaval; Aronow, Wilbert S. // Cardiology;Jun2014, Vol. 128 Issue 3, p251 

    The current American Heart Association/American College of Cardiology guidelines for patients with stable angina pectoris recommend β-blockers as the initial drug therapy for prevention of angina pectoris (class I B indication). Long-acting nitrates or calcium channel blockers should be...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics